Correction to: Clinicians' use of breast cancer risk assessment tools according to their perceived importance of breast cancer risk factors: an international survey
J Community Genet. 2019 Oct;10(4):531.
doi: 10.1007/s12687-019-00431-w.
1 Institut Curie, Supportive Care Department, Psycho-Oncology Unit, 26 rue d'Ulm, 75005, Paris, Cedex 05, France. anne.bredart@curie.net.
2 University Paris Descartes, 71 avenue Edouard Vaillant, 92774, Boulogne-Billancourt, France. anne.bredart@curie.net.
3 Université de Lorraine, 2LPN-CEMA, 23 boulevard Albert 1er-BP, 60446-54001, Cedex Nancy, France.
4 Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Worts Causeway, CB1 8RN, University of Cambridge, Cambridge, UK.
5 Institut Curie, Cancer genetic clinic, 26 rue d'Ulm, 75005, Paris, Cedex 05, France.
6 Department of Medical Genetics, University of Cambridge, Box 238, Level 6 Addenbrooke's Treatment Centre Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.
7 Department of Clinical Genetics, Laboratory Medicine, Office for Medical Services and Department of Clinical Genetics, Lund University, 221 85, Lund, Sweden.
8 Netherlands Cancer Institute, Division of Molecular Pathology, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands.
9 Institut Curie, Supportive Care Department, Psycho-Oncology Unit, 26 rue d'Ulm, 75005, Paris, Cedex 05, France.
10 CESP, University Paris-Sud, UVSQ, INSERM, University Paris-Saclay, 16 avenue Paul Vaillant-Couturier, 94807, Villejuif, France.
11 Familial Breast and Ovarian Cancer Centre, Cologne University, Hospital and Faculty of Medicine, Kerpener Str. 34, I 50931, Cologne, Germany.
12 Department of Human Genetics, Department of Pathology, Leiden University Medical Centre, S4-P, P.O. Box 9600, 2300 RC, Leiden, The Netherlands.